MCRB trade ideas
MCRB Triangle Symmetrical Top (bullish)I found this pattern at tickeron website with the following data:
STATUS = Confirmed
CURRENT CONFIDENCE = 88%
TARGET (EXIT) PRICE = 34.49 USD
BREAKOUT (ENTRY) PRICE = 28.53 USD
DISTANCE TO TARGET PRICE = 18.93%
EMERGED ON = Sep 10, 12:00 PM (EDT)
CONFIRMED ON = Sep 29, 10:10 AM (EDT)
WITH CONFIDENCE LEVEL = 100%
The Symmetrical Triangle Top pattern forms when the price of a security fails to retest a high or low and ultimately forms two narrowing trend lines. The price is expected to move up or down past the triangle depending on which line is broken first. The price movement inside the triangle should fill the shape with some uniformity, without leaving large blank areas.
This pattern is commonly associated with directionless markets since the contraction (narrowing) of the market range signals that neither bulls nor bears are in control. However, there is a distinct possibility that market participants will either pour in or sell out, and the price can move up or down with big volumes (leading up to the breakout).
Trade idea
Once price breaks out from the top pattern boundary, day traders and swing traders should trade with an UP trend. Consider buying a security or a call option at the breakout price level. To identify an exit, compute the target price by adding the pattern height to the breakout point. The pattern height is the difference between the highest high and lowest low within the pattern.
To limit potential loss when price suddenly goes in the wrong direction, consider placing a stop order to sell at or below the breakout price.
pssh im waiting until tomorrow :)its looking like about $15 to $16 a share tomorrow at the low before liftoff
Using Sine waves and Fibonacci Spirals to help find the low point on this current "high rise" still a bear market if you ask 2016 i think. . well at least until another one of them thar peaks coming up awful quickly :)
Don't trust me, I'm new at this :)
Positive Topline Results from SER-109 Phase 3Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection
– SER-109 met Phase 3 primary endpoint, showing a highly statistically significant 30.2% absolute reduction in the rate of C. difficile infection recurrence compared to placebo –
– SER-109 was well tolerated, with a safety profile comparable to placebo –
– Efficacy results substantially exceeded FDA regulatory guidance to support BLA filing as a single pivotal trial; Company to meet with agency to discuss filing for product approval as soon as possible –
– Positive SER-109 Phase 3 data provide validation for Seres’ microbiome therapeutics platform and further development of its pipeline of product candidates –
IN THE NEWS:
-Schaeffer's Investment Research
- Benzinga
- Investor's Business Daily
- MarketWatch
-Motley Fool
finance.yahoo.com
MCRB - Bounce Trend In Flow - Can It Carry On?Seres Therapeutics, Inc. operates a microbiome therapeutics platform company, which engages in the development of biological drugs. The firm creates medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. Berry and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
SHORT INTEREST
4.91M 07/31/19
P/E Current
-1.22
P/E Ratio (with extraordinary items)
-1.71
Average Recommendation: OVERWEIGHT
Average Target Price: 9.60
MCRB - Falling wedge breakout Long from $10.87 to $12.77 MCRB broken out of a falling wedge formation & now breaking out of its resistance zone. We think it will continue upward from here.
* Trade Criteria *
Date First Found- June 20, 2017
Pattern/Why- Falling wedge breakout continuation Long
Entry Target Criteria- Break of $10.87
Exit Target Criteria- $12.77
Stop Loss Criteria- $9.87
Please check back for Trade updates. (Note: Trade update is little delayed here.)